The Reproduction Center, The Third Affiliated Hospital of Zhengzhou University, 7 Kangfuqian Road, Zhengzhou, 450052, Henan, People's Republic of China.
J Ovarian Res. 2018 Jul 16;11(1):59. doi: 10.1186/s13048-018-0432-x.
Improvements in vitrification and frozen embryo transfer (FET) technologies have rapidly increased, and some evidence suggests that FET may increase pregnancy rates and lead to more favourable perinatal outcomes. However, the outcome of interest should be offspring safety. Therefore, the primary objective of our study was to investigate whether FET was preferable to fresh embryo transfer (ET) in terms of full-term neonatal birthweight and congenital malformations.
This was a retrospective cohort study of patients with no pregnancy-related complications who underwent first fresh ETs (n = 2059) or FETs (n = 2053), resulting in full-term singletons births. Outcome measures were neonatal birthweight, low birthweight (LBW), small-for-gestational age (SGA), large-for-gestational age (LGA), macrosomia and congenital malformations. Additionally, we used logistic regression to adjust for baseline characteristics (age, BMI, No. of embryos transferred and embryo stage) between the two groups.
The mean neonatal birthweight was higher for singletons born after FET than for singletons born after fresh ET (3468.7 ± 475.3 vs. 3386.7 ± 448.1; p < 0.001). The frequencies of full-term singleton LBW and SGA after FET were significantly lower than those after fresh ET (1.7% vs. 3.0 and 4.4% vs. 6.7%, respectively), with adjusted rate ratios of 0.59 (95% CI, 0.37 to 0.98; p = 0.026) and 0.73 (95% CI, 0.55 to 0.99; p = 0.041), respectively. FET resulted in higher frequencies of macrosomia and LGA (15.1% vs 10.2 and 22.8% vs. 17.5%, respectively) than fresh ET, with adjusted rate ratios of 1.43 (95% CI, 1.16 to 1.75; p = 0.001) and 1.26 (95% CI, 1.07 to 1.49; p = 0.007), respectively. Furthermore, the incidence of congenital malformations was not different between the two groups (1.2% vs. 0.9%), with a rate ratio of 0.288.
After the cycles with pregnancy-related complications were excluded and after adjustments for baseline characteristics, women undergoing FET were associated with a higher neonatal birthweight than women undergoing fresh ET cycles. Additionally, the FET protocol was associated with lower rates of LBW and SGA and higher rates of macrosomia and LGA than the fresh ET protocol. Meanwhile, no difference in the congenital malformation rate was evident between the two groups.
玻璃化和冷冻胚胎移植(FET)技术的改进迅速提高,一些证据表明 FET 可能提高妊娠率并导致更有利的围产期结局。然而,感兴趣的结果应该是后代的安全性。因此,我们的主要研究目的是调查 FET 是否优于新鲜胚胎移植(ET),在足月新生儿体重和先天性畸形方面。
这是一项回顾性队列研究,纳入了无妊娠相关并发症的患者,她们分别进行了第一次新鲜 ET(n=2059)或 FET(n=2053),最终分娩出足月单胎。结局指标是新生儿体重、低体重儿(LBW)、小于胎龄儿(SGA)、大于胎龄儿(LGA)、巨大儿和先天性畸形。此外,我们使用逻辑回归调整两组之间的基线特征(年龄、BMI、移植胚胎数量和胚胎阶段)。
FET 后出生的单胎新生儿体重明显高于新鲜 ET 后出生的单胎新生儿体重(3468.7±475.3 vs. 3386.7±448.1;p<0.001)。FET 后足月单胎 LBW 和 SGA 的发生率明显低于新鲜 ET 后(1.7% vs. 3.0%和 4.4% vs. 6.7%),调整后的率比分别为 0.59(95%CI,0.37 至 0.98;p=0.026)和 0.73(95%CI,0.55 至 0.99;p=0.041)。FET 后巨大儿和 LGA 的发生率高于新鲜 ET(15.1% vs 10.2%和 22.8% vs. 17.5%),调整后的率比分别为 1.43(95%CI,1.16 至 1.75;p=0.001)和 1.26(95%CI,1.07 至 1.49;p=0.007)。此外,两组先天性畸形的发生率无差异(1.2% vs. 0.9%),率比为 0.288。
在排除与妊娠相关的并发症的周期后,并在调整了基线特征后,接受 FET 的女性的新生儿体重高于接受新鲜 ET 周期的女性。此外,FET 方案与 LBW 和 SGA 的发生率较低,而与巨大儿和 LGA 的发生率较高有关,而两组的先天性畸形发生率无差异。